Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection

Annals of Clinical Microbiology and Antimicrobials

Volumn 4, Issue , 2005, Pages

  Crockett, Seth D ^a   Keeffe, Emmet B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coinfection; Dual infection; HBV HCV; HBV HCV HDV; HBV HCV HIV; Hepatitis B; Hepatitis C; Interferon; Lamivudine; Ribavirin; Treatment; Triple infection

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; INTERFERON; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

CANCER RISK; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; PRACTICE GUIDELINE; REVIEW; SEROCONVERSION; SUPERINFECTION; DRUG COMBINATION; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; DRUG THERAPY, COMBINATION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS;

EID: 26844444126     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-4-13     Document Type: Review

References (68)

1. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994, 74:2442-8.
2. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R: Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999, 85:2132-7.
3. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C: Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995, 2:39-45.
4. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, Hatziyannis S: Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991, 265:1974-6.
5. Lee WM: Hepatitis B virus infection. N Engl J Med 1997, 337:1733-45.
6. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 1999, 74:425-7.
7. Atanasova MV, Haydouchka IA, Zlatev SP, Stoilova YD, Iliev YT, Mateva NG: Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Minerva Gastroenterol Dietol 2004, 50:89-96.
8. Liaw YF: Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995, 22:1101-8.
9. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, Rizzetto M: Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003, 39:1036-41.
10. Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, et al.: Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997, 51:313-8.
11. Liaw YF: Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. J Gastroenterol 2002, 37(Suppl 13):65-8.
12. Liaw YF, Yeh CT, Tsai SL: Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000, 95:2978-80.
13. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM: Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004, 126:1024-9.
14. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S, et al.: Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999, 58:201-7.
15. Fukuda R, Ishimura N, Hamamoto S, Moritani M, Uchida Y, Ishihara S, Akagi S, Watanabe M, Kinoshita Y: Co-infection by serologicallysilent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J Med Virol 2001, 63:220-7.
16. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH: The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991, 14:64-7.
17. Chu CM, Yeh CT, Liaw YF: Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998, 36:2084-6.
18. Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodriguez M, San Miguel G, Artinano E, Pons-Romero F: Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994, 89:1147-51.
19. Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, Chu CM: Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994, 106:1048-53.
20. Liaw YF, Lin SM, Sheen IS, Chu CM: Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination. Infection 1991, 19:250-1.
21. Dai CY, Yu ML, Chuang WL, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY: Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001, 16:636-40.
22. Sheen IS, Liaw YF, Lin DY, Chu CM: Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994, 170:358-61.
23. Utili R, Zampino R, Bellopede P, Marracino M, Ragone E, Adinolfi LE, Ruggiero G, Capasso M, Indolfi P, Casale F, et al.: Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1999, 94:4046-52.
24. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993, 67:5823-32.
25. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S: Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002, 37:855-62.
26. Pontisso P, Gerotto M, Ruvoletto MG, Fattovich G, Chemello L, Tisminetzky S, Baralle F, Alberti A: Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996, 48:157-60.
27. Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, Sato T, Mizuno K, Nonaka S: Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994, 21:159-66.
28. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A: Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993, 105:1529-33.
29. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D: Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998, 28:27-33.
30. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, et al.: Longterm follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 1995, 46:258-64.
31. Doi T, Yamada G, Endo H, Nishimoto H, Takahashi M, Miyamoto R, Fujiki S, Shimomura H, Mizuno M, Tsuji T: Hepatitis type C virus infection in patients with type B chronic liver disease. Gastroenterol Jpn 1992, 27:617-23.
32. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J: Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001, 34:404-10.
33. Liaw YF: Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger? J Gastroenterol Hepatol 2001, 16:597-598.
34. Liaw YF, Chu CM, Chang-Chien CS, Wui CS: Simultaneous acute infections with hepatitis non-A, non-B, and B viruses. Dig Dis Sci 1982, 27:762-4.
35. Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC, Li JS, Vitvitski L, Sninsky JJ, Trepo C: Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 1992, 32:215-20.
36. Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, Vallari DV, Barbosa LH, Nemo GJ: Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. Bmj 1993, 307:1095-7.
37. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F: HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001, 64:350-5.
38. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G: Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999, 341:22-6.
39. Chu CM, Sheen IS, Liaw YF: The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994, 107:189-95.
40. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C: Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993, 104:549-55.
41. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ: Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology 1994, 19:836-40.
42. Mohamed Ael S, al Karawi MA, Mesa GA: Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients. Hepatogastroenterology 1997, 44:1404-6.
43. Kew MC, Yu MC, Kedda MA, Coppin A, Sarkin A, Hodkinson J: The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997, 112:184-7.
44. Lok AS, McMahon BJ: Chronic hepatitis B: update of recommendations. Hepatology 2004, 39:857-61.
45. Strader DB, Wright T, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-71.
46. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February Consensus Statement. European Association for the Study of the Liver. J Hepatol 1999, 30:956-61.
47. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J, et al.: EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003, 39(Suppl 1):S3-25.
48. Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005, 25:472-89.
49. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL: A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004, 2:87-106.
50. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis. Ann Intern Med 1993, 119:312-23.
51. Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, et al.: A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann Intern Med 2005, 142:240-50.
52. Burt M, Chapman BA, Scrimshaw BJ, Jennings LC, George PM: Concurrent hepatitis B and C infection treated successfully with alpha interferon. Aust NZ J Med 1993, 23:411-412.
53. Gehenot M, Marcellin P, Colin JF, Martinot M, Benhamou JP, Erlinger S: Alpha Interferon Therapy in HBsAg Positive Patients with Chronic Hepatitis C. Hepatology 1995, 22:116A.
54. Guptan RC, Thakur V, Raina V, Sarin SK: Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999, 14:893-8.
55. Villa E, Grottola A, Buttafoco P, Colantoni A, Bagni A, Ferretti I, Cremonini C, Bertani H, Manenti F: High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am J Gastroenterol 2001, 96:2973-7.
56. Liaw YF, Chien RN, Lin SM, Yeh CT, Tsai SL, Sheen IS, Chu CM: Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interferon Cytokine Res 1997, 17:449-52.
57. Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS: Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 2003, 37:568-76.
58. Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen CH, Changchien CS: Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol 2005, 20:727-32.
59. Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML: Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Antivir Ther 2005, 10:125-33.
60. Yalcin K, Degertekin H, Yildiz F, Kilinc N: A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. J Gastroenterol 2003, 38:796-800.
61. Marrone A, Zampino R, D'Onofrio M, Ricciotti R, Ruggiero G, Utili R: Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection. J Hepatol 2004, 41:1064-5.
62. United Network of Organ Sharing [http://www.unos.org]. Accessed August 5, 2005
63. Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD: Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996, 23:396-404.
64. Rubio Caballero M, Rubio Rivas C, Nogues Biau A, Manonelles Fernandez A: [Epidemiology of chronic hepatitis C virus in patients infected by human immunodeficiency virus. Study of 767 patients]. Med Clin (Barc) 2005, 125:56-8.
65. Soriano V, Martin-Carbonero L, Garcia-Samaniego J, Puoti M: Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus. Clin Infect Dis 2001, 33:1793-1795.
66. Sterling RK: Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge. Am J Gastroenterol 2003, 98:2130-4.
67. Sterling RK, Sulkowski MS: Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection. Semin Liver Dis 2004, 24(Suppl 2):61-8.
68. Benhamou Y, Bochet M, Thibault V: Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 1999, 30:1302-1306.